Elefant Dov
Related Filers (5)
- Cellectar Biosciences, Inc. (8)
- FEMASYS INC (4)
- Lev Pharmaceuticals Inc (3)
- EPICEPT CORP (2)
- Akari Therapeutics Plc (2)
- Show More ...
Ownership (19)
4
Friday, 2/2/2024
FEMASYS INC: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
FEMASYS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2022
FEMASYS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/1/2022
FEMASYS INC: Initial statement of beneficial ownership of securities
4
Thursday, 1/27/2022
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/5/2021
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/28/2020
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 3/5/2020
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/4/2020
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/11/2019
Cellectar Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/11/2019
Cellectar Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/22/2015
Akari Therapeutics Plc: Statement of changes in beneficial ownership of securities
3
Friday, 1/2/2015
Celsus Therapeutics Plc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/21/2008
Lev Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/20/2007
Lev Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
4
Tuesday, 3/20/2007
Lev Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 1/9/2006
EPICEPT CORP: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/4/2006
EPICEPT CORP: Initial statement of beneficial ownership of securities